BCG side effects do tend to get worse as treatments progress, but the pattern is more nuanced than a simple escalation with every dose. During the standard six-week induction course, urinary frequency and urgency gradually increase in severity, while other symptoms like bladder pain tend to stay mild. Most side effects resolve within 48 hours of each individual treatment, but the baseline level of irritation can build over the course of the cycle.
What Happens During Induction
The six-week induction phase is where most people first notice side effects ramping up. Cystitis symptoms gradually increase during this period, typically peaking at a mild-to-moderate level. Specifically, the urge to urinate frequently and the sense of urgency both worsen as induction proceeds, while bladder pain and burning during urination tend to remain relatively mild throughout. So the worsening isn’t uniform across all symptoms.
The most common side effects during induction include bladder irritation (burning, frequency, urgency), blood in the urine, general fatigue, and low-grade fever. These typically resolve within two days of each instillation and don’t require treatment. Fever that stays above 38.5°C (101.3°F) for more than 48 hours is a different situation and needs medical evaluation, as it could signal a more serious reaction.
Why Repeated Doses Intensify the Response
There’s a biological reason side effects build over time, and understanding it can actually be reassuring. BCG works by training your immune system to attack cancer cells in the bladder lining. Each instillation triggers your immune cells to become more reactive. After about four treatments, your innate immune cells start producing higher levels of inflammatory signaling molecules in the bladder. By the sixth instillation, this heightened immune response extends beyond the bladder to your circulating immune cells throughout the body.
This process, sometimes called “trained immunity,” involves real changes in how your immune cells are programmed. Your body essentially rewrites the instructions for how aggressively immune cells should respond. That reprogramming takes time to develop, which is why the first couple of treatments often feel milder than later ones. The increasing side effects are, in a sense, evidence that the treatment is doing what it’s designed to do.
Induction vs. Maintenance Side Effects
After the initial six-week induction, many treatment plans include maintenance therapy, where you receive periodic BCG instillations over one to three years. Here’s where the pattern gets counterintuitive: individual maintenance treatments tend to cause fewer symptoms than induction treatments. Bladder pain drops from about 44% of patients during induction to 30% during maintenance. Fever falls from roughly 19% to 12%. Cystitis symptoms are cut nearly in half, from 32% to 16%.
However, maintenance stretches on for much longer, and the cumulative burden adds up. Severe side effects requiring treatment cessation actually occur almost twice as frequently in patients on maintenance compared to those who only completed induction. Each individual session may be easier, but the extended timeline means more opportunities for problems to develop. About 20% of patients on a full maintenance schedule eventually stop because of side effects, though proper counseling about what to expect can reduce that discontinuation rate to under 8%.
How Many People Experience Significant Problems
Serious complications from BCG are uncommon. In a study of 276 patients, about 8% developed notable local or systemic side effects. Among those who did have problems, the vast majority (78%) experienced cystitis symptoms rather than anything more severe. Fewer than 9% of affected patients developed a high fever lasting more than 48 hours, and systemic BCG infection requiring treatment cessation is rare.
Overall, roughly one in three patients who start a full maintenance schedule complete it as planned. About one in five stop due to side effects, while others discontinue for unrelated reasons or because the treatment isn’t working. These numbers reflect the reality that BCG therapy is effective but demanding, and tolerability varies widely from person to person.
Dose Reduction as an Option
If your side effects are worsening to the point where continuing feels difficult, dose reduction is a well-studied option. Cutting the standard dose to one-third has been shown in multiple trials to provide similar protection against cancer recurrence and progression while significantly reducing both local and systemic side effects. Fewer patients on the reduced dose needed to delay treatments or stop therapy altogether. This approach is particularly useful for people with high-risk tumors who need to stay on BCG but are struggling with tolerability.
Your treatment team can also adjust the schedule, delaying an instillation to give your bladder more recovery time. The goal is to keep you on therapy long enough for it to work without the side effects becoming unbearable.
What Recovery Looks Like Between Treatments
After each instillation, the typical pattern is 24 to 48 hours of bladder irritation, fatigue, and possibly mild fever, followed by resolution. If your symptoms consistently clear within that window, the treatment is generally proceeding as expected, even if those 48 hours feel rougher with each successive dose. The key signals that something has shifted from normal inflammation to a more serious reaction are fever above 101.3°F lasting beyond two days, symptoms that don’t improve between treatments, or new symptoms appearing in joints, lungs, or other organs, which could indicate BCG has spread beyond the bladder.
Keeping a simple log of your symptoms after each treatment, noting severity and how long they last, gives you and your care team concrete information to work with. If the pattern shows clear escalation in duration or intensity rather than just a modest uptick, that’s useful data for deciding whether to adjust the dose or schedule.